Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response

Clinical trial NCT07582887 · RECRUITING

Trial details

NCT number: NCT07582887
Sponsor: Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Metastatic Breast Cancer Drug-Related Side Effects and Adverse Reactions Pharmacogenetic Variant

Start date: 2025-07-15
Primary completion: 2026-12-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.